OSF Saint Anthony Medical Center

Summary

OSF Saint Anthony Medical Center is a medical facility located in Rockford, Illinois. This center is recognized for care of Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Breast cancer, Colorectal Cancer and other specialties. OSF Saint Anthony Medical Center is involved with conducting 65 clinical trials across 103 conditions. There are 2 research doctors associated with this hospital, such as Shylendra B. Sreenivasappa and Iftekhar U. Ahmad.

Top PIs

Clinical Trials running at OSF Saint Anthony Medical Center

Lung Cancer

Breast Cancer

Breast cancer

Colorectal Cancer

Cancer

Non-Small Cell Lung Cancer

Bladder Cancer

Prostate Cancer

Lymphoma

Melanoma

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.

Recruiting

2 awards

Phase 3

27 criteria

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Observation

for Non-Small Cell Lung Cancer

GEMINI NSCLC Study is a non-interventional study that will be collecting clinical and molecular health information from patients with NSCLC who will receive longitudinal blood collection in addition to their standard of care therapy and disease surveillance with the goals of identifying the molecular evolution of lung cancer with standard of care therapy, and determining the utility of ctDNA dynamics to predict risk of recurrence and therapeutic outcomes.

Recruiting

1 award

N/A

10 criteria